Brief: Biosergen Q4 EBITDA SEK -12.49 Million
10/02/2026 07:30
Feb 10 (Reuters) - Biosergen Q4 net income SEK -12.463 million. Q4 EPS SEK -5.31
BIOSGN — Biosergen AB News Story
0.000.00%
Last trade - 00:00- SEK17.61m
- -SEK5.10m
Last trade - 00:00Last trade - 00:00Feb 10 (Reuters) - Biosergen Q4 net income SEK -12.463 million. Q4 EPS SEK -5.31